Central nervous system agents in the treatment of erectile dysfunction

Urologic Clinics of North America

Volumn 32, Issue 4, 2005, Pages 487-501

  Kendirci, Muammer ^a   Walls, Melissa M ^a   Hellstrom, Wayne J G ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; APOMORPHINE; BACLOFEN; CENTRAL NERVOUS SYSTEM AGENTS; CLOZAPINE; DOMPERIDONE; DOPAMINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; EP 50885; EP 60761; GROWTH HORMONE RELEASING FACTOR; HALOPERIDOL; HEXARELIN; HORMONE RECEPTOR STIMULATING AGENT; MELANOTAN II; N METHYL DEXTRO ASPARTIC ACID; NITRIC OXIDE SYNTHASE INHIBITOR; OXYTOCIN ANTAGONIST; PHOSPHODIESTERASE V INHIBITOR; RSD 992; SEROTONIN 2C AGONIST; SILDENAFIL; TRAZODONE; UNCLASSIFIED DRUG; YOHIMBINE;

APPETITE DISORDER; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; DIZZINESS; ERECTILE DYSFUNCTION; HEADACHE; HUMAN; NAUSEA; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIAPISM; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STRETCHING; YAWNING;

APOMORPHINE; CENTRAL NERVOUS SYSTEM AGENTS; CLINICAL TRIALS; DOPAMINE AGONISTS; HUMANS; IMPOTENCE; MALE;

EID: 27744517842     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ucl.2005.08.006     Document Type: Review

References (137)

1. K.E. Andersson Pharmacology of penile erection Pharmacol Rev 53 3 2001 417 450
2. H. Padma-Nathan, W.D. Steers, and P.A. Wicker Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double-blind, placebo-controlled study of 329 patients. Sildenafil Study Group Int J Clin Pract 52 6 1998 375 379
3. M.S. Rendell, J. Rajfer, and P.A. Wicker Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group JAMA 281 5 1999 421 426
4. A. McCullough, K. Woo, and S. Telegrafi Is sildenafil failure in men after radical retropubic prostatectomy (RRP) due to arterial disease? Penile duplex Doppler findings in 174 men after RRP Int J Impot Res 14 6 2002 462 465
5. D.G. Hatzichristou Sildenafil citrate: lessons learned from 3 years of clinical experience Int J Impot Res 14 Suppl 1 2002 S43 S52
6. A. Bjorklund, O. Lindvall, and A. Nobin Evidence of an incerto-hypothalamic dopamine neurone system in the rat Brain Res 89 1 1975 29 42
7. K.E. Andersson, and G. Wagner Physiology of penile erection Physiol Rev 75 1 1995 191 236
8. K.K. Chen, J.Y. Chan, and L.S. Chang Dopaminergic neurotransmission at the paraventricular nucleus of hypothalamus in central regulation of penile erection in the rat J Urol 162 1 1999 237 242
9. E.M. Hull, R.C. Eaton, and V.P. Markowski Opposite influence of medial preoptic D1 and D2 receptors on genital reflexes: implications for copulation Life Sci 51 22 1992 1705 1713
10. V.P. Markowski, R.C. Eaton, and L.A. Lumley D1 agonist in the MPOA facilitates copulation in male rats Pharmacol Biochem Behav 47 3 1994 483 486
11. C.S. Carter Oxytocin and sexual behavior Neurosci Biobehav Rev 16 2 1992 131 144
12. A. Argiolas, M.R. Melis, and A. Mauri Paraventricular nucleus lesion prevents yawning and penile erection induced by apomorphine and oxytocin but not by ACTH in rats Brain Res 421 1-2 1987 349 352
13. M.R. Melis, S. Succu, and A. Argiolas Dopamine agonists increase nitric oxide production in the paraventricular nucleus of the hypothalamus: correlation with penile erection and yawning Eur J Neurosci 8 10 1996 2056 2063
14. F. Giuliano, and O. Rampin Central neural regulation of penile erection Neurosci Biobehav Rev 24 5 2000 517 533
15. F. Giuliano, and O. Rampin Central noradrenergic control of penile erection Int J Impot Res 12 S1 2000 S13 S19
16. S. Lal, D. Ackman, and J.X. Thavundayil Effect of apomorphine, a dopamine receptor agonist, on penile tumescence in normal subjects Prog Neuropsychopharmacol Biol Psychiatry 8 4-6 1984 695 699
17. P. Danjou, L. Alexandre, and D. Warot Assessment of erectogenic properties of apomorphine and yohimbine in man Br J Clin Pharmacol 26 6 1988 733 739
18. O. Rampin Mode of action of a new oral treatment for erectile dysfunction: apomorphine SL BJU Int 88 Suppl 3 2001 22 24
19. J.P. Mulhall Sublingual apomorphine for the treatment of erectile dysfunction Expert Opin Investig Drugs 11 2 2002 295 302
20. G.C. Hsieh, P.R. Hollingsworth, and B. Martino Central mechanisms regulating penile erection in conscious rats: the dopaminergic systems related to the proerectile effect of apomorphine J Pharmacol Exp Ther 308 1 2004 330 338
21. O. Rampin, N. Jerome, and C. Suaudeau Proerectile effects of apomorphine in mice Life Sci 72 21 2003 2329 2336
22. V.G. Mirone, and C.G. Stief Efficacy of apomorphine SL in erectile dysfunction BJU Int 88 Suppl 3 2001 25 29
23. E. Dula, S. Bukofzer, and R. Perdok Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction Eur Urol 39 5 2001 558 563 [discussion 564]
24. J.P. Heaton, J. Dean, and D.J. Sleep Sequential administration enhances the effect of apomorphine SL in men with erectile dysfunction Int J Impot Res 14 1 2002 61 64
25. J. Buvat, and F. Montorsi Safety and tolerability of apomorphine SL in patients with erectile dysfunction BJU Int 88 Suppl 3 2001 30 35
26. J.P. Mulhall, S. Bukofzer, and A.L. Edmonds An open-label, uncontrolled dose-optimization study of sublingual apomorphine in erectile dysfunction Clin Ther 23 8 2001 1260 1271
27. E. Dula, W. Keating, and P.F. Siami Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction. The Apomorphine Study Group Urology 56 1 2000 130 135
28. P. Perimenis, S. Markou, and K. Gyftopoulos Efficacy of apomorphine and sildenafil in men with nonarteriogenic erectile dysfunction. A comparative crossover study Andrologia 36 3 2004 106 110
29. P. Perimenis, K. Gyftopoulos, and K. Giannitsas A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arteriogenic erectile dysfunction Int J Impot Res 16 1 2004 2 7
30. I. Eardley, P. Wright, and R. MacDonagh An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction BJU Int 93 9 2004 1271 1275
31. A.T. Von Keitz, P. Stroberg, and S. Bukofzer A European multicentre study to evaluate the tolerability of apomorphine sublingual administered in a forced dose-escalation regimen in patients with erectile dysfunction BJU Int 89 4 2002 409 415
32. K.E. Andersson, and P. Hedlund New directions for erectile dysfunction therapies Int J Impot Res 14 Suppl 1 2002 S82 S92
33. M. Kendirci, and W.J. Hellstrom Intranasal apomorphine. Nastech Pharmaceutical IDrugs 7 5 2004 483 488
34. K.E. Andersson, H. Gemalmaz, and K. Waldeck The effect of sildenafil on apomorphine-evoked increases in intracavernous pressure in the awake rat J Urol 161 5 1999 1707 1712
35. K.E. Andersson Pharmacology of erectile function and dysfunction Urol Clin North Am 28 2 2001 233 247
36. Y. Tang, O. Rampin, and A. Calas Oxytocinergic and serotonergic innervation of identified lumbosacral nuclei controlling penile erection in the male rat Neuroscience 82 1 1998 241 254
37. J. Rehman, A. Kaynan, and G. Christ Modification of sexual behavior of Long-Evans male rats by drugs acting on the 5-HT1A receptor Brain Res 821 2 1999 414 425
38. D. Bitran, and E.M. Hull Pharmacological analysis of male rat sexual behavior Neurosci Biobehav Rev 11 4 1987 365 389
39. W.C. de Groat, and A.M. Booth Neural control of penile erection. Vol. 6 1993 Harwood Academic Publishers London
40. L. Marlier, J.R. Teilhac, and C. Cerruti Autoradiographic mapping of 5-HT1, 5-HT1A, 5-HT1B and 5-HT2 receptors in the rat spinal cord Brain Res 550 1 1991 15 23
41. K.B. Thor, S. Nickolaus, and C.J. Helke Autoradiographic localization of 5-hydroxytryptamine1A, 5-hydroxytryptamine1B and 5-hydroxytryptamine1C/2 binding sites in the rat spinal cord Neuroscience 55 1 1993 235 252
42. G. Bagdy, K.T. Kalogeras, and K. Szemeredi Effect of 5-HT1C and 5-HT2 receptor stimulation on excessive grooming, penile erection and plasma oxytocin concentrations Eur J Pharmacol 229 1 1992 9 14
43. M. Bancila, D. Verge, and O. Rampin 5-Hydroxytryptamine2C receptors on spinal neurons controlling penile erection in the rat Neuroscience 92 4 1999 1523 1537
44. M.J. Millan, J.L. Peglion, and G. Lavielle 5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists Eur J Pharmacol 325 1 1997 9 12
45. M. Bos, F. Jenck, and J.R. Martin Novel agonists of 5HT2C receptors. Synthesis and biological evaluation of substituted 2-(indol-1-yl)-1- methylethylamines and 2-(indeno[1,2-b]pyrrol-1-yl)-1-methylethylamines. Improved therapeutics for obsessive compulsive disorder J Med Chem 40 17 1997 2762 2769
46. M.R. Melis, and A. Argiolas Role of central nitric oxide in the control of penile erection and yawning Prog Neuropsychopharmacol Biol Psychiatry 21 6 1997 899 922
47. K.M. Azadzoi, T. Payton, and R.J. Krane Effects of intracavernosal trazodone hydrochloride: animal and human studies J Urol 144 5 1990 1277 1282
48. F.J. Monsma Jr., Y. Shen, and R.P. Ward Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs Mol Pharmacol 43 3 1993 320 327
49. W.D. Steers, and W.C. de Groat Effects of m-chlorophenylpiperazine on penile and bladder function in rats Am J Physiol 257 6 Pt 2 1989 R1441 R1449
50. I. Saenz de Tejada, J.C. Ware, and R. Blanco Pathophysiology of prolonged penile erection associated with trazodone use J Urol 145 1 1991 60 64
51. W. Meinhardt, P.I. Schmitz, and R.F. Kropman Trazodone, a double blind trial for treatment of erectile dysfunction Int J Impot Res 9 3 1997 163 165
52. R.A. Costabile, and M. Spevak Oral trazodone is not effective therapy for erectile dysfunction: a double-blind, placebo controlled trial J Urol 161 6 1999 1819 1822
53. E.S. Hayes Pro-erectile effect of novel seratonin agonists Int J Impot Res 12 Suppl 3 2000 S62
54. J.T. Clark, E.R. Smith, and J.M. Davidson Evidence for the modulation of sexual behavior by alpha-adrenoceptors in male rats Neuroendocrinology 41 1 1985 36 43
55. A.T. Guay, R.F. Spark, and J. Jacobson Yohimbine treatment of organic erectile dysfunction in a dose-escalation trial Int J Impot Res 14 1 2002 25 31
56. T. Lebret, J.M. Herve, and P. Gorny Efficacy and safety of a novel combination of L-arginine glutamate and yohimbine hydrochloride: a new oral therapy for erectile dysfunction Eur Urol 41 6 2002 608 613 [discussion 613]
57. P. Kunelius, J. Hakkinen, and O. Lukkarinen Is high-dose yohimbine hydrochloride effective in the treatment of mixed-type impotence? A prospective, randomized, controlled double-blind crossover study Urology 49 3 1997 441 444
58. M.R. Melis, M.S. Spano, and S. Succu EP 60761- and EP 50885-induced penile erection: structure-activity studies and comparison with apomorphine, oxytocin and N-methyl-D-aspartic acid Int J Impot Res 12 5 2000 255 262
59. M.R. Melis, S. Succu, and M.S. Spano Penile erection induced by EP 80661 and other hexarelin peptide analogues: involvement of paraventricular nitric oxide Eur J Pharmacol 411 3 2001 305 310
60. M.R. Melis, S. Succu, and M.S. Spano EP 60761 and EP 50885, two hexarelin analogues, induce penile erection in rats Eur J Pharmacol 404 1-2 2000 137 143
61. M.R. Melis, R. Stancampiano, and A. Argiolas Prevention by NG-nitro-L-arginine methyl ester of apomorphine- and oxytocin-induced penile erection and yawning: site of action in the brain Pharmacol Biochem Behav 48 3 1994 799 804
62. M.R. Melis, R. Stancampiano, and A. Argiolas Penile erection and yawning induced by paraventricular NMDA injection in male rats are mediated by oxytocin Pharmacol Biochem Behav 48 1 1994 203 207
63. M.R. Melis, R. Stancampiano, and A. Argiolas Nitric oxide synthase inhibitors prevent N-methyl-D-aspartic acid-induced penile erection and yawning in male rats Neurosci Lett 179 1-2 1994 9 12
64. A.R. Zahran, P. Vachon, and F. Courtois Increases in intracavernous penile pressure following injections of excitatory amino acid receptor agonists in the hypothalamic paraventricular nucleus of anesthetized rats J Urol 164 5 2000 1793 1797
65. M.R. Melis, S. Succu, and U. Iannucci N-methyl-D-aspartic acid-induced penile erection and yawning: role of hypothalamic paraventricular nitric oxide Eur J Pharmacol 328 2-3 1997 115 123
66. A. Argiolas Nitric oxide is a central mediator of penile erection Neuropharmacology 33 11 1994 1339 1344
67. F. Giuliano, O. Rampin, and K. Brown Stimulation of the medial preoptic area of the hypothalamus in the rat elicits increases in intracavernous pressure Neurosci Lett 209 1 1996 1 4
68. N.G. Bowery, A.L. Hudson, and G.W. Price GABAA and GABAB receptor site distribution in the rat central nervous system Neuroscience 20 2 1987 365 383
69. R. Magoul, B. Onteniente, and M. Geffard Anatomical distribution and ultrastructural organization of the GABAergic system in the rat spinal cord. An immunocytochemical study using anti-GABA antibodies Neuroscience 20 3 1987 1001 1009
70. I. Elekes, A. Patthy, and T. Lang Concentrations of GABA and glycine in discrete brain nuclei. Stress-induced changes in the levels of inhibitory amino acids Neuropharmacology 25 7 1986 703 709
71. A. Fernandez-Guasti, K. Larsson, and C. Beyer GABAergic control of masculine sexual behavior Pharmacol Biochem Behav 24 4 1986 1065 1070
72. A. Fernandez-Guasti, K. Larsson, and C. Beyer Comparison of the effects of different isomers of bicuculline infused in the preoptic area on male rat sexual behavior Experientia 41 11 1985 1414 1416
73. M.R. Melis, S. Succu, and M.S. Spano Effect of excitatory amino acid, dopamine, and oxytocin receptor antagonists on noncontact penile erections and paraventricular nitric oxide production in male rats Behav Neurosci 114 4 2000 849 857
74. A. Argiolas, M.R. Melis, and G.L. Gessa Oxytocin: an extremely potent inducer of penile erection and yawning in male rats Eur J Pharmacol 130 3 1986 265 272
75. A. Argiolas Oxytocin stimulation of penile erection. Pharmacology, site, and mechanism of action Ann N Y Acad Sci 652 1992 194 203
76. K. Chen, and L.S. Chang Oxytocinergic neurotransmission at the hippocampus in the central neural regulation of penile erection in the rat Urology 58 1 2001 107 112
77. M.R. Murphy, J.R. Seckl, and S. Burton Changes in oxytocin and vasopressin secretion during sexual activity in men J Clin Endocrinol Metab 65 4 1987 738 741
78. A. Argiolas, M.R. Melis, and L. Vargiu (CH2)5Tyr(Me)-[Orn8]vasotocin, a potent oxytocin antagonist, antagonizes penile erection and yawning induced by oxytocin and apomorphine, but not by ACTH-(1-24) Eur J Pharmacol 134 2 1987 221 224
79. M.R. Melis, A. Mauri, and A. Argiolas Apomorphine-and oxytocin-induced penile erection and yawning in intact and castrated male rats: effect of sexual steroids Neuroendocrinology 59 4 1994 349 354
80. A. Argiolas, M.R. Melis, and R. Stancampiano Oxytocin-induced penile erection and yawning: role of calcium and prostaglandins Pharmacol Biochem Behav 35 3 1990 601 605
81. M.R. Melis, S. Succu, and U. Iannucci Oxytocin increases nitric oxide production in the paraventricular nucleus of the hypothalamus of male rats: correlation with penile erection and yawning Regul Pept 69 2 1997 105 111
82. P. Cushman Jr. Sexual behavior in heroin addiction and methadone maintenance. Correlation with plasma luteinizing hormone N Y State J Med 72 11 1972 1261 1265
83. T.K. McIntosh, M.L. Vallano, and R.J. Barfield Effects of morphine, beta-endorphin and naloxone on catecholamine levels and sexual behavior in the male rat Pharmacol Biochem Behav 13 3 1980 435 441
84. M.R. Melis, R. Stancampiano, and G.L. Gessa Prevention by morphine of apomorphine- and oxytocin-induced penile erection and yawning: site of action in the brain Neuropsychopharmacology 6 1 1992 17 21
85. M.R. Melis, S. Succu, and U. Iannucci Prevention by morphine of apomorphine- and oxytocin-induced penile erection and yawning: involvement of nitric oxide Naunyn Schmiedebergs Arch Pharmacol 355 5 1997 595 600
86. M.R. Melis, S. Succu, and A. Argiolas Prevention by morphine of N-methyl-D-aspartic acid-induced penile erection and yawning: involvement of nitric oxide Brain Res Bull 44 6 1997 689 694
87. M.R. Melis, S. Succu, and M.S. Spano Morphine injected into the paraventricular nucleus of the hypothalamus prevents noncontact penile erections and impairs copulation: involvement of nitric oxide Eur J Neurosci 11 6 1999 1857 1864
88. Y. Sato, G.J. Christ, and H. Horita The effects of alterations in nitric oxide levels in the paraventricular nucleus on copulatory behavior and reflexive erections in male rats J Urol 162 6 1999 2182 2185
89. Y. Sato, H. Horita, and T. Kurohata Effect of the nitric oxide level in the medial preoptic area on male copulatory behavior in rats Am J Physiol 274 1 Pt 2 1998 R243 R247
90. K.K. Chen, S.H. Chan, and L.S. Chang Participation of paraventricular nucleus of hypothalamus in central regulation of penile erection in the rat J Urol 158 1 1997 238 244
91. M.R. Melis, and A. Argiolas Nitric oxide synthase inhibitors prevent apomorphine- and oxytocin-induced penile erection and yawning in male rats Brain Res Bull 32 1 1993 71 74
92. M.R. Melis, and A. Argiolas Nitric oxide donors induce penile erection and yawning when injected in the central nervous system of male rats Eur J Pharmacol 294 1 1995 1 9
93. R. Poggioli, A. Benelli, and R. Arletti Nitric oxide is involved in the ACTH-induced behavioral syndrome Peptides 16 7 1995 1263 1268
94. M.R. Melis, S. Succu, and A. Mauri Nitric oxide production is increased in the paraventricular nucleus of the hypothalamus of male rats during non-contact penile erections and copulation Eur J Neurosci 10 6 1998 1968 1974
95. A.L. Burnett, S. Saito, and M.P. Maguire Localization of nitric oxide synthase in spinal nuclei innervating pelvic ganglia J Urol 153 1 1995 212 217
96. S. Saito, G.J. Kidd, and B.D. Trapp Rat spinal cord neurons contain nitric oxide synthase Neuroscience 59 2 1994 447 456
97. N.J. Dun, S.L. Dun, and S.Y. Wu Nitric oxide synthase immunoreactivity in the rat, mouse, cat and squirrel monkey spinal cord Neuroscience 54 4 1993 845 857
98. I. Gantz, and T.M. Fong The melanocortin system Am J Physiol Endocrinol Metab 284 3 2003 E468 E474
99. J.E. Wikberg Melanocortin receptors: perspectives for novel drugs Eur J Pharmacol 375 1-3 1999 295 310
100. H. Wessells, V.J. Hruby, and J. Hackett MT-II induces penile erection via brain and spinal mechanisms Ann N Y Acad Sci 994 2003 90 95
101. A. Bertolini, and G.L. Gessa Behavioral effects of ACTH and MSH peptides J Endocrinol Invest 4 2 1981 241 251
102. T. Gura Having it all Science 299 5608 2003 850
103. A. Argiolas, M.R. Melis, and S. Murgia ACTH- and alpha-MSH-induced grooming, stretching, yawning and penile erection in male rats: site of action in the brain and role of melanocortin receptors Brain Res Bull 51 5 2000 425 431
104. A. Argiolas Neuropeptides and sexual behaviour Neurosci Biobehav Rev 23 8 1999 1127 1142
105. K.G. Mountjoy, M.T. Mortrud, and M.J. Low Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain Mol Endocrinol 8 10 1994 1298 1308
106. Y. Konda, I. Gantz, and J. DelValle Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor J Biol Chem 269 18 1994 13162 13166
107. I. Kojima, K. Kojima, and H. Rasmussen Role of calcium and cAMP in the action of adrenocorticotropin on aldosterone secretion J Biol Chem 260 7 1985 4248 4256
108. S. Kapas, A. Purbrick, and J.P. Hinson Role of tyrosine kinase and protein kinase C in the steroidogenic actions of angiotensin II, alpha-melanocyte-stimulating hormone and corticotropin in the rat adrenal cortex Biochem J 305 Pt 2 1995 433 438
109. R. Vemulapalli, S. Kurowski, and B. Salisbury Activation of central melanocortin receptors by MT-II increases cavernosal pressure in rabbits by the neuronal release of NO Br J Pharmacol 134 8 2001 1705 1710
110. L.H. Van der Ploeg, W.J. Martin, and A.D. Howard A role for the melanocortin 4 receptor in sexual function Proc Natl Acad Sci USA 99 17 2002 11381 11386
111. W.J. Martin, E. McGowan, and D.E. Cashen Activation of melanocortin MC(4) receptors increases erectile activity in rats ex copula Eur J Pharmacol 454 1 2002 71 79
112. P.B. Molinoff, A.M. Shadiack, and D. Earle PT-141: a melanocortin agonist for the treatment of sexual dysfunction Ann N Y Acad Sci 994 2003 96 102
113. J.E. Wikberg, R. Muceniece, and I. Mandrika New aspects on the melanocortins and their receptors Pharmacol Res 42 5 2000 393 420
114. H.B. Schioth, F. Mutulis, and R. Muceniece Discovery of novel melanocortin4 receptor selective MSH analogues Br J Pharmacol 124 1 1998 75 82
115. A.V. Vergoni, A. Bertolini, and F. Mutulis Differential influence of a selective melanocortin MC4 receptor antagonist (HS014) on melanocortin-induced behavioral effects in rats Eur J Pharmacol 362 2-3 1998 95 101
116. A.V. Vergoni, A. Bertolini, and G. Guidetti Chronic melanocortin 4 receptor blockage causes obesity without influencing sexual behavior in male rats J Endocrinol 166 2 2000 419 426
117. W.J. Martin, and D.E. MacIntyre Melanocortin receptors and erectile function Eur Urol 45 6 2004 706 713
118. P. Trivedi, M. Jiang, and C.C. Tamvakopoulos Exploring the site of anorectic action of peripherally administered synthetic melanocortin peptide MT-II in rats Brain Res 977 2 2003 221 230
119. J.B. Tatro, and M.L. Entwistle Heterogeneity of brain melanocortin receptors suggested by differential ligand binding in situ Brain Res 635 1-2 1994 148 158
120. J. Lindblom, H.B. Schioth, and A. Larsson Autoradiographic discrimination of melanocortin receptors indicates that the MC3 subtype dominates in the medial rat brain Brain Res 810 12 1998 161 171
121. I. Gantz, H. Miwa, and Y. Konda Molecular cloning, expression, and gene localization of a fourth melanocortin receptor J Biol Chem 268 20 1993 15174 15179
122. H. Wessells, V.J. Hruby, and J. Hackett Ac-Nle-c[Asp-His-DPhe-Arg-Trp- Lys]-NH2 induces penile erection via brain and spinal melanocortin receptors Neuroscience 118 3 2003 755 762
123. H. Mizusawa, P. Hedlund, and K.E. Andersson alpha-Melanocyte stimulating hormone and oxytocin induced penile erections, and intracavernous pressure increases in the rat J Urol 167 2 Pt 1 2002 757 760
124. Y.K. Yang, D.A. Thompson, and C.J. Dickinson Characterization of Agouti-related protein binding to melanocortin receptors Mol Endocrinol 13 1 1999 148 155
125. M.A. Bednarek, T. MacNeil, and R.N. Kalyani Selective, high affinity peptide antagonists of alpha-melanotropin action at human melanocortin receptor 4: their synthesis and biological evaluation in vitro J Med Chem 44 22 2001 3665 3672
126. M.R. Melis, and A. Argiolas Central oxytocinergic neurotransmission: a drug target for the therapy of psychogenic erectile dysfunction Curr Drug Targets 4 1 2003 55 66
127. R.A. Adan, and W.H. Gispen Brain melanocortin receptors: from cloning to function Peptides 18 8 1997 1279 1287
128. N. Sabatier, C. Caquineau, and G. Dayanithi Alpha-melanocyte-stimulating hormone stimulates oxytocin release from the dendrites of hypothalamic neurons while inhibiting oxytocin release from their terminals in the neurohypophysis J Neurosci 23 32 2003 10351 10358
129. F. Giuliano, J. Bernabe, and K. McKenna Spinal proerectile effect of oxytocin in anesthetized rats Am J Physiol Regul Integr Comp Physiol 280 6 2001 R1870 R1877
130. H. Wessells, K. Fuciarelli, and J. Hansen Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study J Urol 160 2 1998 389 393
131. H. Wessells, D. Gralnek, and R. Dorr Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction Urology 56 4 2000 641 646
132. R.C. Rosen, L.E. Diamond, and D.C. Earle Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra Int J Impot Res 16 2 2004 135 142
133. L.E. Diamond, D.C. Earle, and R.C. Rosen Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction Int J Impot Res 16 1 2004 51 59
134. H.B. Schioth, A.A. Bouifrouri, and R. Rudzish Pharmacological comparison of rat and human melanocortin 3 and 4 receptors in vitro Regul Pept 106 1-3 2002 7 12
135. H.B. Schioth, R. Muceniece, and J.E. Wikberg Selectivity of [Phe-I7], [Ala6], and [D-Ala4,Gln5,Tyr6] substituted ACTH(4-10) analogues for the melanocortin receptors Peptides 18 5 1997 761 763
136. V.J. Hruby, D. Lu, and S.D. Sharma Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors J Med Chem 38 18 1995 3454 3461
137. I.K. Sebhat, W.J. Martin, and Z. Ye Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist J Med Chem 45 21 2002 4589 4593